CAVACURMIN®, developed by WACKER, is an innovative curcumin complex that addresses the common challenge of curcumin’s poor absorption due to its fat solubility. By utilizing gamma-cyclodextrin (CAVAMAX® W8), a naturally occurring oligosaccharide, to form a complex with curcumin, CAVACURMIN® significantly enhances its absorption and bioavailability. Specifically, it achieves a 40-fold increase in absorption and an 18-fold higher bioavailability compared to standard turmeric extract.

CAVACURMIN® represents a significant advancement in curcumin supplementation, providing a more effective, efficient, and versatile option for those seeking the health benefits of curcumin.

€5.00 / per monthly pack, in standard packaging quality

Health Benefits: General Wellness Immune Support Metabolic Support

ORDER DETAILS:

Packaging: 30 capsules
Minimum Order Quantity: 10.000
Subtotal: (calculating...)
*If you are interested in the price of the active ingredient, please do not hesitate to contact us directly for more information.
Terms: Prices are Ex Works and exclude VAT.
Production Lead Time: Approximately 12 weeks from order confirmation.

CAVACURMIN® contains natural turmeric extract and gamma-cyclodextrin forming a complex trough non-valent bonding, which results in improved bioavailability, dispersity and stability
CAVACURMIN® offers a 40-fold increase in absorption compared to standard turmeric extract.
CAVACURMIN® results in an 18-fold higher bioavailability of curcumin due to its innovative complexation process.
CAVACURMIN® is a free-flowing, easily dispersible powder thanks to the complexation with gamma-cyclodextrin.
CAVACURMIN® enables effective dosages with lower amounts, making it a cost-efficient ingredient in health supplement formulations.
CAVACURMIN® can be incorporated into a wide range of products, including capsules, tablets, beverages, and functional foods, offering manufacturers flexibility in product development.

CAVACURMIN® contributes to cardiovascular health by improving endothelial function and reducing inflammation.
CAVACURMIN® supports healthy aging through its potent antioxidant properties that help combat oxidative stress.
CAVACURMIN® enhances sports performance by reducing muscle soreness and improving recovery times, making it beneficial for athletes.
CAVACURMIN® supports joint health by reducing inflammation and pain associated with conditions like arthritis, thanks to its powerful anti-inflammatory properties.
CAVACURMIN® aids in digestive health by stimulating bile production, which helps with digestion and may alleviate symptoms of indigestion and bloating.
CAVACURMIN® promotes cognitive function by increasing levels of Brain-Derived Neurotrophic Factor (BDNF), which may help improve memory and protect against neurodegenerative diseases.
CAVACURMIN® enhances immune function due to its antioxidant and anti-inflammatory effects, which help strengthen the immune system and protect against infections.
CAVACURMIN® may help in weight management by regulating metabolism and reducing the proliferation of fat cells, supporting overall weight loss efforts.

*These statements have not been evaluated by the US Food & Drug Administration or the European Food and Safety Authority. This product is not intended to diagnose, treat, cure, or prevent any disease.

Several studies have shown:

In Vivo Bioavailability in a Rodent Model (2009): Animals (rats) that received CAVACURMIN® had 8 to 20 times more total curcuminoids in their blood plasma (expressed as the sum of free curcumin and its metabolites) than animals that received a commercial product or pure curcumin powder.
In Vitro Bioavailability in a Human Caco-2 Model (2011): CAVACURMIN® dissolved up to five times more efficiently than leading commercial curcumin supplement products or curcumin powder itself.
Human Bioavailability in a Clinical Study (2013): CAVACURMIN® was about 40 times more efficiently absorbed than leading commercial curcumin supplement products or curcumin powder itself.
Positive effect of CAVACURMIN® on “men’s health (2023): positive effect of CAVACURMIN® on prostate volume, lower urinary tract symptoms and micturition parameters in men with benign prostate enlargement after 1 year of therapy.